The prevailing system for diagnosis, treatment, and management of Autism Spectrum Disorders (ASDs) in the US-the in-person service delivery-has been unable to address the increase in the demand for services and societal costs for those served, and the unattained societal benefits for those not diagnosed early enough or not offered early and intensive behavioral interventions. The authors discuss new developments in telehealth for diagnostic evaluation and ASD treatment in the US.
Behavior Imaging’s related research was featured at the annual American Academy of Child and Adolescent Psychiatry (AACAP) meeting on October 27th, 2016 in New York City. CEO Ron Oberleitner presented on the company’s evidence-supported ‘asynchronous telehealth’ applications for diagnosis and treatment for autism spectrum disorder. See abstract.
This new Clinical Perspectives Session was led by Dr. Kathleen Myers – University of Washington.
Formal publication of Behavior Imaging and other novel telehealth systems presented here will be described in an upcoming publication.